MEDP (Medpace Holdings) Price-to-Operating-Cash-Flow : 16.11 (As of May. 31, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Price-to-Operating-Cash-Flow?

As of today (2025-05-31), Medpace Holdings's share price is $294.64. Medpace Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $18.29. Hence, Medpace Holdings's Price-to-Operating-Cash-Flow Ratio for today is 16.11.

The historical rank and industry rank for Medpace Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

MEDP' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.83 Med: 17.48 Max: 31.6
Current: 16.11

During the past 12 years, Medpace Holdings's highest Price-to-Operating-Cash-Flow Ratio was 31.60. The lowest was 10.83. And the median was 17.48.

MEDP's Price-to-Operating-Cash-Flow is ranked worse than
50.83% of 120 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.185 vs MEDP: 16.11

Medpace Holdings's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $4.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $18.29.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Medpace Holdings was 15.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 39.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 28.90% per year.

During the past 12 years, Medpace Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.10% per year. The lowest was -0.40% per year. And the median was 27.15% per year.

Medpace Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medpace Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Price-to-Operating-Cash-Flow Chart

Medpace Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

20.29

31.16

18.43

22.52

17.47

Medpace Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															25.42	24.35	18.59	17.47	16.66

Competitive Comparison of Medpace Holdings's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Medpace Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medpace Holdings's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Medpace Holdings Price-to-Operating-Cash-Flow Calculation

Medpace Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	294.64	/	18.289
	=	16.11

Medpace Holdings's Share Price of today is $294.64.
Medpace Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.29.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Medpace Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (NAS:MEDP) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

MEDP:Mexico 1MEDP:Italy 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Executives

Davenport Fred B Jr	director
Stephen P Ewald	officer: General Counsel & Corp. Secy.	C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227
Brian T Carley	director	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Robert O. Kraft	director	ONE CVS DRIVE, WOONSOCKET RI 02895
Susan E Burwig	officer: Exec. VP, Operations	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
August J. Troendle	director, 10 percent owner, officer: CEO	5375 MEDPACE WAY, CINCINNATI OH 45227
Ashley M. Keating	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Investors, Llc	10 percent owner	4620 WESLEY AVENUE, CINCINNATI OH 45212
Jesse J Geiger	officer: CFO & COO, Lab Operations	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Kevin M. Brady	officer: CFO & Treasurer	MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Femida H. Gwadry-sridhar	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Mccarthy Cornelius P. Iii	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Tom C King	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Limited Partnership	10 percent owner	EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP
Cinven Capital Management (v) General Partner Ltd	10 percent owner	EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP